gluco-galacto-oligosaccharide
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00810160)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- gluco-galacto-oligosaccharide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02796872 | N/A | Jun 1, 2016 | Clasado Biosciences |
| NCT02628652 | N/A | Oct 1, 2015 | Kaleido Biosciences |
| NCT01848535 | N/A | May 1, 2013 | Wageningen University |
| NCT00810160 | Phase 1 | Jun 1, 2009 | National Institutes of Health (NIH), University of California, Davis |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Clasado Biosciences | For profit | 1 | 1 | 1 | 2016 |
| Kaleido Biosciences | For profit | 1 | 1 | 1 | 2015 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2009 |
| University of California, Davis | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Wageningen University | Academic/Hospital | 1 | 1 | 1 | 2013 |
5 organizations
Page 1 / 1